Letter by de Boer and van Veldhuisen regarding article, "Risk of Thromboembolism in Heart Failure: An Analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)"

被引：1
作者：
de Boer, Rudolf A. [1 ]
van Veldhuisen, Dirk J. [1 ]
机构：
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Thoraxctr, Groningen, Netherlands
来源：
CIRCULATION | 2008年 / 117卷 / 01期
关键词：
D O I：
10.1161/CIRCULATIONAHA.107.725440
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E7 / E7
页数：1
相关论文
共 5 条
[1]   Warfarin anticoagulation and survival: A cohort analysis from the studies of left ventricular dysfunction [J].
Al-Khadra, AS ;
Salem, DN ;
Rand, WM ;
Udelson, JE ;
Smith, JJ ;
Konstam, MA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (04) :749-753
[2]   Both antiplatelet and anticoagulant therapy may favorably affect outcome in patients with advanced heart failure. A retrospective analysis of the PRIME-II trial [J].
de Boer, RA ;
Hillege, HL ;
Tjeerdsma, G ;
Verheugt, FWA ;
van Veldhuisen, DJ .
THROMBOSIS RESEARCH, 2005, 116 (04) :279-285
[3]   Risk of thromboembolism in heart failure - An analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) [J].
Freudenberger, Ronald S. ;
Hellkamp, Anne S. ;
Halperin, Jonathan L. ;
Poole, Jeanne ;
Anderson, Jill ;
Johnson, George ;
Mark, Daniel B. ;
Lee, Kerry L. ;
Bardy, Gust H. .
CIRCULATION, 2007, 115 (20) :2637-2641
[4]   Ventricular dysfunction and the risk of stroke after myocardial infarction [J].
Loh, E ;
Sutton, MSJ ;
Wun, CCC ;
Rouleau, JL ;
Flaker, GC ;
Gottlieb, SS ;
Lamas, GA ;
Moye, LA ;
Goldhaber, SZ ;
Pfeffer, MA .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (04) :251-257
[5]   Warfarin versus aspirin in patients with reduced cardiac ejection fraction (WARCEF): Rationale, objectives, and design [J].
Pullicino, P ;
Thompson, JLP ;
Barton, B ;
Levin, B ;
Graham, S ;
Freudenberger, RS .
JOURNAL OF CARDIAC FAILURE, 2006, 12 (01) :39-46
1